David A. Lipson

Conversion to tacrolimus (FK506) from cyclosporine after orthotopic lung transplantation.

H. Palevsky, D. Lipson, R. Kotloff, 1998, Transplantation proceedings.

The IMPACT Study – Single Inhaler Triple Therapy (FF/UMEC/VI) Versus FF/VI And UMEC/VI In Patients With COPD: Efficacy And Safety In A Japanese Population

A. S. Gross, D. Lipson, T. Ishii, 2019, International journal of chronic obstructive pulmonary disease.

The IMPACT Study – Single Inhaler Triple Therapy (FF/UMEC/VI) Versus FF/VI And UMEC/VI In Patients With COPD: Ef fi cacy And Safety In A Japanese Population

A. S. Gross, K. Hashimoto, Takeo Ishii, 2019 .

Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial

F. Martinez, G. Criner, D. Halpin, 2020, Respiratory Research.

COPD_A_291967 499..517

D. Halpin, P. Jones, M. Bafadhel, 2021 .

A Combined Pulmonary-Radiology Workshop for Visual Evaluation of COPD: Study Design, Chest CT Findings and Concordance with Quantitative Evaluation

Joyce D. Schroeder, Meilan K. Han, E. Regan, 2012, COPD.

Effect of chronic mucus hypersecretion on treatment responses to inhaled therapies in patients with chronic obstructive pulmonary disease: Post hoc analysis of the IMPACT trial

Meilan K. Han, F. Martinez, G. Criner, 2022, Respirology.

Apical perfusion fraction as a predictor of short-term functional outcome following bilateral lung volume reduction surgery.

A. Alavi, L. Kaiser, D. Lipson, 2001, Chest.

How can the findings of the EMAX trial on long-acting bronchodilation in chronic obstructive pulmonary disease be applied in the primary care setting?

E. Kerwin, L. Tombs, I. Naya, 2023, Chronic respiratory disease.